BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26458343)

  • 1. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.
    Dasgupta S; Dutta J; Annamaneni S; Kudugunti N; Battini MR
    Indian J Med Res; 2015 Sep; 142(3):276-85. PubMed ID: 26458343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
    Song DK; Lee H; Hong YS; Sung YA
    BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
    Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study.
    Haldar D; Agrawal N; Patel S; Kambale PR; Arora K; Sharma A; Tripathi M; Batra A; Kabi BC
    Eur J Nutr; 2018 Mar; 57(2):703-711. PubMed ID: 28008453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women.
    Siddamalla S; Reddy TV; Govatati S; Erram N; Deenadayal M; Shivaji S; Bhanoori M
    Gynecol Endocrinol; 2018 Feb; 34(2):161-165. PubMed ID: 28868946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
    Szafarowska M; Dziech E; Kaleta B; Kniotek M; Rogowski A; Segiet-Święcicka A; Jerzak M
    J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study.
    Santos BR; Lecke SB; Spritzer PM
    Reprod Biol Endocrinol; 2018 Apr; 16(1):38. PubMed ID: 29669566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome.
    El-Shal AS; Shalaby SM; Aly NM; Rashad NM; Abdelaziz AM
    Mol Biol Rep; 2013 Nov; 40(11):6063-73. PubMed ID: 24078159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS.
    Zadeh-Vakili A; Ramezani Tehrani F; Daneshpour MS; Zarkesh M; Saadat N; Azizi F
    Gene; 2013 Feb; 515(1):193-6. PubMed ID: 23246977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case-control study of lower Silesian women.
    Jedrzejuk D; Łaczmański Ł; Milewicz A; Kuliczkowska-Płaksej J; Lenarcik-Kabza A; Hirnle L; Zaleska-Dorobisz U; Lwow F
    Gynecol Endocrinol; 2015; 31(12):976-9. PubMed ID: 26422783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
    Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population.
    Singh I; Lavania M; Pathak VK; Ahuja M; Turankar RP; Singh V; Sengupta U
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006823. PubMed ID: 30481178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in vitamin D receptor gene, but not vitamin D levels, are associated with polycystic ovary syndrome in Brazilian women.
    Xavier LB; Gontijo NA; Rodrigues KF; Cândido AL; Dos Reis FM; de Sousa MCR; Silveira JN; Oliveira Silva IF; Ferreira CN; Gomes KB
    Gynecol Endocrinol; 2019 Feb; 35(2):146-149. PubMed ID: 30182771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tumour suppressor gene (TP53, BRCA1 and BRCA2) polymorphisms on polycystic ovary syndrome in South Indian women.
    Siddamalla S; Reddy TV; Govatati S; Guruvaiah P; Deenadayal M; Shivaji S; Bhanoori M
    Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():13-18. PubMed ID: 29860059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor 1a promotor -1521 G/C and -1012 A/G polymorphisms in polycystic ovary syndrome.
    Lin MW; Tsai SJ; Chou PY; Huang MF; Sun HS; Wu MH
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):565-71. PubMed ID: 23276559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of type 2 diabetes mellitus genes in polycystic ovary syndrome aetiology among women from southern India.
    Reddy BM; Kommoju UJ; Dasgupta S; Rayabarapu P
    Indian J Med Res; 2016 Sep; 144(3):400-408. PubMed ID: 28139539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women.
    Shaikh N; Dadachanji R; Meherji P; Shah N; Mukherjee S
    Gene; 2016 Feb; 577(2):180-6. PubMed ID: 26625974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D.
    Jain R; von Hurst PR; Stonehouse W; Love DR; Higgins CM; Coad J
    Metabolism; 2012 Mar; 61(3):293-301. PubMed ID: 21871642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of VDR gene polymorphisms and vitamin D levels in normal and overweight patients with PCOS.
    Saǧlam ZMI; Bakir VL; Ataş MN; Ergen HA
    J Genet; 2024; 103():. PubMed ID: 38258318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.
    Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Hollis BW; Giovannucci E
    Prostate; 2007 Jun; 67(9):911-23. PubMed ID: 17440943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.